<ѻý>Low-Dose Tamoxifen Feasible Option in Breast Cancerѻý> Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<ѻý>ASH Poster Rounds: Obesity Impacts CLL Survival in Womenѻý> Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
<ѻý>Xeloda Disappoints in Early Triple-Negative Breast Cancerѻý> No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
<ѻý>T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca?ѻý> Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
<ѻý>Cancer-VTE Trial Falls Shortѻý> High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<ѻý>Chemo-Free Tx Tops Best Option in Younger CLL Patientsѻý> Improved overall survival and safety with ibrutinib-based therapy Dec 04, 2018
<ѻý>Combination Regimen Extends PFS in Myelomaѻý> Large benefit but relevance of comparator questioned Dec 04, 2018
<ѻý>$2 Test Could Transform Sickle Cell Dx in Africaѻý> May have applications in high-income countries as well Dec 04, 2018
<ѻý>ASH Offers Early Look at Updated SCD Guidelinesѻý> Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
<ѻý>Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapiesѻý> Studies test addition of targeted agents, immunotherapy Dec 03, 2018
<ѻý>SABCS: Translational Before It Was Coolѻý> Growing, evolving while adhering to founding principles Dec 03, 2018
<ѻý>CAR T-Cell Responses Prove Durable in ALL, DLBCLѻý> Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
<ѻý>Cutting Chemo Cycles Feasible in Younger DLBCL Patientsѻý> Patients, ages 18-60, fare well with four cycles of CHOP instead of six Dec 01, 2018
<ѻý>Ibrutinib Alone Wins in Older CLL Patientsѻý> Adding rituximab offered no added benefit Dec 01, 2018
<ѻý>Younger High-Risk Women Benefit From Mammographyѻý> Yields in 30-39 age group at high risk comparable to 40-49 group with average risk Nov 30, 2018
<ѻý>Sneak Peek at Practice-Changing Research From ASH 2018ѻý> "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
<ѻý>Machine Learning Allows for Low-Dose Gadolinium Contrastѻý> Minimal loss of resolution with 10% Gd dose Nov 30, 2018
<ѻý>Morning Break: Measles Rebound; New FDA Warnings; Cancer Dx Scaresѻý> Health news and commentary from around the Web gathered by the ѻý staff Nov 30, 2018
<ѻý>LMWH Prevails for VTE Prevention in Guidelineѻý> ASH unveils first six chapters of comprehensive recommendations Nov 29, 2018
<ѻý>FDA Approves Rituximab Biosimilar for NHLѻý> Indications for front line or beyond, single agent or combination Nov 28, 2018
<ѻý>YouTube Videos Often Mislead on Prostate Cancerѻý> Misinformation, bias, and lack of balance in content Nov 28, 2018
<ѻý>Digital Mammograms Show Vulnerability to Cyberattacksѻý> Two out of three radiologists couldn't tell that images were manipulated Nov 28, 2018
<ѻý>Implants May Still Hinder FFDM with Tomosynthesisѻý> Presence of breast implants tied to decreased recall rates and cancer detection rates Nov 26, 2018
<ѻý>Women 75 and Older Benefit from Annual Mammoѻý> Significant number of invasive cancers found Nov 26, 2018
<ѻý>No Surgery May Be Feasible in Gleason 9-10 Prostate Caѻý> Study finds similar outcomes with two multimodal approaches Nov 23, 2018
<ѻý>Highlights from Molecular Targets Symposiuimѻý> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻý>'My Cancer Free Life'? Not So Fastѻý> Reality docuseries as a commercial for quack doc Nov 15, 2018
<ѻý>AMA Urges Coverage for Added Breast Cancer Screeningѻý> Resolution aimed at women with dense breasts Nov 13, 2018
<ѻý>Regular Aspirin Use Tied to Reduction in HCC Riskѻý> Significant benefit apparent after ≥5 years of use at average dose of at least 1.5 tablets/week Nov 13, 2018
<ѻý>Simple Ovarian Cysts Hold No Cancer Riskѻý> Malignancy extremely rare, don't need surveillance Nov 12, 2018
<ѻý>AHA: Fish Oil, Vitamin D Not VITAL to Heart Healthѻý> VITAL trial also showed no benefits for cancer incidence with both supplements Nov 10, 2018 video
<ѻý>NCRI: Highlights from the Annual Conferenceѻý> Prostate cancer tradeoffs, rising melanoma mortality, safer regimen for thyroid cancer Nov 05, 2018
<ѻý>Morning Break: Dead-Butt Syndrome; Last Word on Cellphone Radiation; States vs Pharmaѻý> Health news and commentary from around the Web gathered by the ѻý staff Nov 02, 2018
<ѻý>Pouch Creation a Winner After Total Gastrectomyѻý> Meta-analysis reports better long-term functional outcomes, no greater perioperative morbidity Oct 30, 2018
<ѻý>SGLT-2 for Stage 3 CKD; Opioids for CKD; Kidney Transplant Discard & Disabilitiesѻý> Roundup of more top abstracts from Kidney Week 2018 Oct 30, 2018
<ѻý>High-Dose Iron an Option for Maintenance Hemodialysisѻý> High-dose noninferior to low-dose, required less erythropoiesis-stimulating agent Oct 28, 2018
<ѻý>Ideal Timing of Post-Mohs Reconstructionѻý> Waiting 7 days or more associated with reduced complications Oct 26, 2018
<ѻý>Survival Bump with Palbociclib in HR+ Breast Cancerѻý> But benefit limited to subgroups; study may have been underpowered Oct 25, 2018
<ѻý>Group of Blood Pressure Drugs Linked to Lung Cancerѻý> 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
<ѻý>Hippocampus-Sparing Radiation a New Option in Brain Mets Patientsѻý> Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018